BioAtla Agrees to $22.5 Million in Financing Agreements

MT Newswires Live11-21

BioAtla (BCAB) said Friday it entered prepaid advance and standby equity purchase agreements that provide access to up to $22.5 million in financing.

The prepaid advance totals $7.5 million of face value with roughly $7.1 million gross proceeds, the company said.

The advance carries 4% interest and can be repaid in cash or converted into shares at the lower of $1.39 or 95% of the lowest recent volume weighted average trading price, it said.

The advance carries 4% interest and can be repaid in cash or converted into shares at the lower of $1.39 or 95% of the lowest recent volume weighted average trading price, it said.

The financing is intended to support operations, the company added.

Shares of the company were up by over 3.4% in recent Friday premarket activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment